![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 31, 21598-21602, July 30, 1999
From the Thyroid Division, Department of Medicine, Brigham and
Women's Hospital and Harvard Medical School,
Boston, Massachusetts 02115.
Thioredoxin reductases (TRR) serve critical roles
in maintaining cellular redox states. Two isoforms of TRR have been
identified in mammals: both contain a penultimate selenocysteine
residue that is essential for catalytic activity. A search of the
genome of the invertebrate, Caenorhabditis elegans, reveals
a gene highly homologous to mammalian TRR, with a TGA selenocysteine
codon at the corresponding position. A selenocysteyl-tRNA was
identified in this organism several years ago, but no selenoproteins
have been identified experimentally. Herein we report the first
identification of a C. elegans selenoprotein. By
75Se labeling of C. elegans, one major band was
identified, which migrated with the predicted mobility of the C. elegans TRR homologue. Western analysis with an antibody against
human TRR provides strong evidence for identification of the C. elegans selenoprotein as a member of the TRR family. The
3'-untranslated region of this gene contains a selenocysteine insertion
sequence (SECIS) element that deviates at one position from the
previously invariant consensus "AUGA." Nonetheless, this element
functions to direct selenocysteine incorporation in mammalian cells,
suggesting conservation of the factors recognizing SECIS elements from
worm to man.
The synthesis of selenoproteins requires several specialized
components of the translational machinery (reviewed in Ref. 1). In
addition to tRNASec and the enzymes necessary for
generation of charged selenocysteyl-tRNASec, this process
requires a selenocysteine specific elongation factor, SelB, identified
so far only in prokaryotes. Specific secondary structures in the
mRNAs of selenoproteins are required to distinguish UGA
selenocysteine codons from stop codons. These structures, termed
selenocysteine insertion sequence
(SECIS)1 elements, are
located adjacent to the UGA codons in prokaryotes and in the 3'-UTR of
selenoprotein mRNAs in eukaryotes (2). Eukaryotic SECIS elements
are characterized by a small number of conserved nucleotides at
specific positions in the stem-loop. These are foremost, the invariable
sequence motif "AUGA," which pairs with "GA" opposite each
other on the 5' and 3' arms of the stem, respectively, and two or three
adenosines in either the terminal loop or an internal bulge. In all
vertebrate selenoprotein mRNAs identified to date these sequences
are highly conserved. Mutagenesis studies have shown that the conserved
nucleotides and secondary structural features are necessary to suppress
the stop codon function of a UGA codon and to decode it as
selenocysteine (3, 4).
The ability to synthesize selenoproteins is of fundamental importance
in mammals, as deletion of the gene for selenocysteyl-tRNA leads to an
embryonic lethal phenotype in a mouse model (5). The selenoprotein or
proteins responsible for this lethality have not been determined.
Cytoplasmic glutathione peroxidase, a selenoprotein functioning in
breakdown of toxic hydroperoxides, appears not to be critical for
normal development of mammals, probably due to redundancy in the
glutathione peroxidase gene family (6). Among the 13 eukaryotic
selenoproteins identified to date, thioredoxin reductase (TRR) is a
strong candidate for an essential selenoprotein. TRR is a disulfide
oxidoreductase with a broad substrate specificity; it reduces among
many other substrates the active site disulfide in oxidized
thioredoxin. Thioredoxin (TR) is an important cofactor in a large
number of biological processes. While a knockout model for TRR has not
been reported to date, targeted disruption of the TR gene causes early
embryonic lethality, and TRR is the only known reductant of TR (7).
Two TRR isoforms have been described in several mammalian species, both
of which contain a UGA codon encoding selenocysteine as the penultimate
C-terminal amino acid (8-12). Putative SECIS elements are present in
the 3'-UTRs of both sequences. In contrast to other selenoenzymes, it
has been proposed that the selenocysteine residues in the TRRs are not
in the predicted catalytic site, but function to carry reducing
equivalents from the active site to substrates (13). Nonetheless,
selenocysteine is critical for reducing thioredoxin, as demonstrated by
the loss of activity upon chemical alteration (14) or proteolytic
removal of this amino acid (13).
The C. elegans gene for selenocysteyl-tRNA was identified by
Lee et al. in 1990 (15), indicating that selenoprotein genes would likely be present. To date, no selenoproteins have been experimentally identified in C. elegans. Since the complete
genome of C. elegans has been sequenced, and this organism
is amenable to genetic studies, it promises to be a valuable model
system for the study of eukaryotic selenoprotein synthesis. In this
study, we show that C. elegans expresses at least one
selenoprotein. This protein migrates with the predicted size of a
thioredoxin reductase homologue in the C. elegans sequence
data base. We further show that the selenium-labeled protein reacts in
Western blotting analysis with an antibody prepared against a human TRR
peptide, providing evidence for its identification as a TRR homologue. Finally, we report identification and characterization of a functional SECIS element in the 3'UTR of the C. elegans TRR gene. This
SECIS element deviates at a previously invariant position from all
vertebrate SECIS elements reported to date, but functions to direct
selenocysteine incorporation in a mammalian cell line.
75Se Labeling of C. elegans--
C.
elegans strain bristol (N2) was used throughout these studies
(16). For 75Se labeling of worms, their food source,
Escherichia coli strain OP50, was grown overnight in 1 ml of
Luria broth medium containing 20 µCi of 75Se.
75Se-labeled bacteria were harvested by pelleting,
resuspended in M9 buffer (22 mM
KH2PO4, 42 mM
Na2HPO4, 85 mM NaCl, 1 mM MgSO4), and dispensed on 60-mm plates
containing 3 ml of nematode growth medium agar. Worms were grown at
22 °C on lawns of 75Se-labeled E. coli and
harvested by washing them off the plates in M9 buffer, followed by
sedimentation at 800 × g for 5 min and three washes in
M9 buffer. The pellets were resuspended in phosphate-buffered saline
and sonicated. As a protease inhibitor 1 mM
phenylmethylsulfonyl fluoride was added. Lysates were stored at
Sequences of Genes and cDNAs from C. elegans--
All of the
predicted protein sequences were first identified in the genomic
sequences generated by the C. elegans Genome Sequencing Consortium. The TBLASTN algorithm was run against the Washington University Genome Sequencing Center C. elegans data base to
identify sequences that encode proteins with homology to mammalian
selenoproteins. We identified a gene with 71% sequence similarity to
human (h)TRR (GenBankTM accession number 2500117). This
sequence was used to search the GenBankTM expressed
sequence tag data base and led to the identification of the cDNA
clone yk384f6 (provided by Y. Kohara, National Institute of Genetics,
Mishima, Japan). The cDNA sequence of yk384f6 was determined by
automated sequencing (Applied Biosystems, Foster City, CA). The
sequence of this cDNA clone confirmed the predicted intron/exon junctions.
RNA Isolation and 3'-Rapid Amplification of cDNA
Ends--
Total RNA was isolated from mixed stage populations of
C. elegans. Worms were first ground into a fine powder using
a liquid nitrogen-cooled mortar and pestle. Powdered C. elegans (200 mg) were homogenized in 2 ml of TRIzol (Life
Technologies, Inc.). RNA was collected from the aqueous phase following
the addition of chloroform, precipitated by adding isopropyl alcohol,
and air-dried. First strand cDNA was synthesized by reverse
transcriptase using oligo(dT) as primer and used as template in PCR
with primers flanking the predicted start and stop codon. The PCR
product was sequenced with primer CB 122 (see below) by automated sequencing.
Constructs--
The minimal SECIS element of TRR was generated
by PCR using the overlapping primers CB122
(CCAAGCTTTAGGCGGGTGACGACCTTTGGCTAAACT) and CB124
(GGGCGGCCGCCATCAGACCAGAGGCGCTCACGATGG). The mutant SECIS element (for
construct 151) was generated using primer CB123, CCAAGCTTTAGGCGGGTAACGACCTTTGGCTAAACT (mutation
indicated in bold). Constructs 150 (wild type SECIS) and 151 (mutant
SECIS) were derived by subcloning the PCR fragments (via
HindIII and NotI) into a construct expressing rat
D1 (G16D10 DNA Transfections and 5'-Deiodinase Assays--
All constructs
were cotransfected with plasmid pTKGH, a thymidine kinase
promoter-directed human growth hormone-expressing plasmid, into HEK-293
cells by calcium phosphate precipitation as described previously (17).
Transfection efficiencies were monitored by assay of human growth
hormone in the media. Cell sonicates were assayed for the presence of
5' deiodinase activity as described previously (18). Deiodinase
activities were calculated per microliter of cell sonicate and
normalized to amount of growth hormone secreted into the media.
Electrophoresis and Immunoblot Analyses--
Typically 200 µg
of crude 75Se-labeled C. elegans homogenate was
combined with 5× SDS-PAGE sample buffer (0.3125 M
Tris-HCl, 4% Identification of Selenoproteins in C. elegans--
To identify
selenoproteins in C. elegans, we developed a
75Se labeling technique based on their food source,
bacteria. E. coli were cultured in Luria broth media
containing 75Se. This led to incorporation of
75Se predominantly into two E. coli
selenoproteins. Worms were allowed to feed on a lawn of
75Se-labeled bacterial for 24 h, until bacteria were
depleted, then harvested for analysis of 75Se
incorporation. Since there are always trace amounts of bacteria in the
gut of C. elegans, we also prepared a lysate of the
75Se-labeled bacteria. SDS-PAGE analysis of C. elegans homogenate reveals three major selenoprotein bands, two in
the 80-95 kDa size range and one of ~58 kDa. The two upper bands are
also present in the bacterial lysate and correspond in size to the
isoforms of bacterial formate dehydrogenases (19). The most prominent selenoprotein in C. elegans, which is not found in the
bacterial lysate, is the 58-kDa protein (Fig.
1). Thus, the 58-kDa band likely
represents a C. elegans selenoprotein. In control
experiments we treated the C. elegans lysate with RNase A. No difference in labeling pattern was seen compared with the untreated
lysate, suggesting that none of the bands visible by autoradiography
are of RNA origin (data not shown).
TRR Is the Only Eukaryotic Selenoprotein Homologue in C. elegans
with a UGA Selenocysteine Codon--
We performed a search of the
C. elegans genome data base with the sequences of all known
mammalian selenoproteins. This search revealed a gene highly homologous
to mammalian TRR, with a TGA selenocysteine codon at the corresponding
position (Fig. 2, GenBankTM
accession number 1397273). No homologues of any of the three isoforms
of the iodothyronine deiodinases, selenoprotein P, or selenoprotein W
were found. Homologues of glutathione peroxidases, selenophosphate
synthetase (Sps2), and a 15-kDa selenoprotein (20) are present, but
each contains a cysteine codon in place of the TGA selenocysteine
codon found in the corresponding mammalian gene. Thus, the C. elegans thioredoxin reductase is the only homologue of a known
mammalian selenoprotein containing a conserved selenocysteine codon.
Assignment of the 58-kDa Selenoprotein as a Member of the TRR
Family--
To obtain evidence for the identity of the
75Se-labeled 58-kDa protein as a thioredoxin reductase-like
protein, we performed Western analysis using a polyclonal antibody
against human TRR. The antibody was raised against an hTRR peptide
sequence, which shares 17 of 21 amino acids (81% identity) with the
corresponding C. elegans sequence (Fig. 2) and thus might be predicted
to cross-react with the worm protein. Western analysis of the
75Se-labeled C. elegans lysate revealed an
antibody-reactive protein of the predicted size (Fig.
3, hTRR antibody) and two additional cross-reacting bands. After extensive washing of the membrane and decay
of the chemiluminescent signal, we used autoradiography to visualize
the 75Se-labeled band. Superimposing the autoradiograph and
chemiluminescence film revealed that the C. elegans-specific 58-kDa
75Se-labeled band and one of the three Western blot bands
comigrated precisely (Fig. 3, 75Se labeling), providing
strong evidence for identification of the 75Se-labeled band
as a TRR homologue. The presence of additional cross-reacting bands
prompted us to further examine the C. elegans data base for other
sequences bearing homology to the human TRR peptide. After TRR, the
next highest scoring matches were the glutathione reductase (GR)
sequence and an uncharacterized pyridine nucleotide-disulfide
oxidoreductase, C46F11, both exhibiting 57% identity (Fig. 2). GR and
C46F11 do not contain UGA selenocysteine codons and do not correspond
in their predicted sizes to the 58-kDa protein identified by
75Se labeling. The predicted molecular masses of GR and
C46F11 are 55 and 51.5 kDa, respectively.
Identification of a Putative SECIS Element in C. elegans
TRR--
We next searched the sequence of the C. elegans
TRR 3'-UTR for a potential SECIS element. Although there are several
"AUGA" motifs in the 3'-UTR, none appeared in the context of a
SECIS element. However, by extending the search to sequences which are similar but not identical to this motif, we identified a putative SECIS
element that deviates from the vertebrate consensus by one nucleotide.
The worm element, beginning with "GUGA" instead of "AUGA", is
predicted to fold like a vertebrate form 2 SECIS element with a
characteristic 10-base pair stem, an adenosine bulge, and an upper stem
and small terminal loop (Fig. 4).
The C. elegans TRR SECIS Element Is Functional in Mammalian
Cells--
To investigate the ability of this putative SECIS element
to direct selenocysteine incorporation in a mammalian cell line, we
generated a construct containing the TRR SECIS element linked to the
rat D1 coding region. This construct was transiently transfected into
the human embryonic kidney-derived cell line HEK-293, and production of
deiodinase activity was assessed. We have shown previously that a
functional SECIS element is required for incorporation of
selenocysteine into this protein, which in turn is required for maximal
deiodinase activity (21) (18). The putative C. elegans SECIS
element directed selenocysteine incorporation at an activity level
slightly higher (134 ± 1.6%) than the wild type rat D1 SECIS
element. Mutation of the invariant "G," the third nucleotide in the
"AUGA" motif, in either the rat glutathione peroxidase or rat D1
SECIS elements was shown previously to reduce activity to ~6% (22)
or to undetectable levels (3) (17), respectively. In the C. elegans SECIS element, this "G" to "A" mutation (Fig. 4)
also resulted in near complete inactivation (3% of rat D1).
In this study, we report identification of the first selenoprotein
and the first SECIS element in C. elegans. The protein migrates with the apparent molecular weight of a thioredoxin reductase homologue in the sequence data base and exhibits antibody
cross-reactivity with members of this family of enzymes. Blast searches
against the genome sequence of C. elegans (1998 number 85)
using the protein sequences of all known vertebrate selenoproteins
revealed the TRR sequence to be the only homologue of a vertebrate
selenoprotein with a UGA codon at the corresponding position (Fig. 2).
It has been speculated that this C. elegans homologue might
be a selenoprotein based on the presence of the conserved UGA codon
(23). Herein, we provide experimental evidence supporting the identity
of the major C. elegans selenoprotein as TRR by Western
analysis of 75Se-labeled C. elegans homogenates
and autoradiography of the same membrane, allowing superimposition of
the two films. Our labeling studies indicate that this protein is by
far the most prominent selenoprotein in C. elegans. In
addition to the putative TRR homologue, a 75Se-labeled band
migrating at ~40 kDa was detected with varying intensity in different
labeling experiments. The identity and source of this band are unknown;
it may represent a degradation product derived from proteolysis of
either the putative worm TRR or one of the bacterial selenoproteins.
All vertebrate selenoproteins contain at least one SECIS element, which
is required for decoding UGA as a selenocysteine codon. An "AUGA"
motif within the structural context of a SECIS element is invariant in
all previously characterized eukaryotic selenoprotein sequences. Only
after searching for SECIS-like structures, while allowing for
deviations from the consensus, did we identify a putative stem loop
structure meeting the requirements of a form 2 SECIS element. In this
SECIS element, a "GUGA" motif is present instead of "AUGA".
This sequence still allows formation of the "GA quartet" shown
recently to be critical for SECIS function in vertebrates (3). More
importantly, the C. elegans TRR SECIS element directs
selenocysteine incorporation in a mammalian cell line. Finally, a point
mutation disrupting the ability to form the "GA quartet" resulted
in near complete loss of activity, consistent with this element
functioning analogously to mammalian SECIS elements. This suggests that
the mechanism of selenocysteine incorporation may be evolutionarily
conserved in eukaryotes.
It is not known whether the "GUGA" motif is specific for nematodes.
The existence of an expressed sequence tag clone from the filarial
nematode Onchocerca volvulus encoding a TRR homologue with a
UGA codon at the corresponding position (GenBankTM
accession number AA680606) suggests that in this subspecies TRR is also
a selenoprotein. The sequence of the 3'-UTR, which would allow the
search for a SECIS element in this gene, remains to be determined.
Since the genome of C. elegans has been completely
sequenced, this sequence information could lead to the identification
of components of the translational machinery required for selenoprotein synthesis. The genome of C. elegans contains
selenocysteyl-tRNA (Sel C) and selenophosphate synthetase (Sel D)
genes, the only two components of the selenoprotein translational
machinery identified in eukaryotes to date. Interestingly, whereas
Drosophila and humans have two forms of selenophosphate
synthetase (Sel D), one form being itself a selenoprotein, C. elegans has only one (Y45F10A.4, GenBankTM accession
number 3880988). This Sel D homologue exhibits similarity to both Sel D
type 1 (50% identity) and type 2 (52% identity), but contains a
cysteine codon at the position corresponding to Sec 63 in human Sel D
type 2. A partial cDNA sequence from another filarial nematode,
Brugia malayi indicates the presence of a
cysteine-containing Sel D homologue (GenBankTM accession
number AA585621).
Glutathione peroxidase (GPX) is a selenoenzyme in vertebrates, but in
C. elegans, as well as in the filarial nematodes
Dirofilaria immiti and Brugia phalangi, the
homologues to GPX contain cysteine residues substituted for
selenocysteine in the active site. The Dirofilaria immiti
version of GPX exhibits a low level GPX activity compared with
selenocysteine-containing GPX, when expressed in a bacterial expression
system (24). This might indicate that in evolutionary terms it is more
important to have a highly active, selenocysteine-containing TRR than a
highly active GPX, providing the selective pressure to maintain the
translational machinery required for selenoprotein synthesis.
Since the genome of Saccharomyces cerevisiae does not
contain genes for selenocysteyl-tRNA or selenophosphate synthetase, and
no selenoproteins have been identified experimentally in yeast, genetic
studies of selenoprotein synthesis in eukaryotes have not been feasible
to date. C. elegans could thus provide a long awaited model
system for genetic dissection of this process in higher organisms. The
technique of RNA-mediated interference in C. elegans and the
facility of generating transgenic worms offer powerful approaches for
studying selenoprotein synthesis, as well as the functions of this
important redox protein in basal cellular processes and in development.
Thanks go to Martin Viktor (Harvard Medical
School, Boston, MA) for advice on C. elegans culture
techniques, to Y. Kohara (National Institute of Genetics, Mishima,
Japan) for promptly providing the expressed sequence tag clone to
Manusha Ujwal for help with the alignment (Harvard Medical School,
Boston, MA), and to John Gasdaska (Arizona Cancer Center, Tucson, AZ)
for human TRR antiserum.
While this manuscript was in review, a
publication describing 75Se labeling and partial purification
of the C. elegans thioredoxin reductase appeared in press
(25).
*
This work was supported by the Reimar Luest grant from the
Koerber Foundation (to C. B.) and by National Institutes of Health Grants DK47320 and DK 52963 (to M. J. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF162693.
The abbreviations used are:
SECIS, selenocysteine insertion sequence;
D1, type 1 deiodinase;
GPX, glutathione peroxidase;
GR, glutathione reductase;
PAGE, polyacrylamide
gel electrophoresis;
PCR, polymerase chain reaction;
TR, thioredoxin;
TRR, thioredoxin reductase;
UTR, untranslated region.
The Caenorhabditis elegans Homologue of Thioredoxin
Reductase Contains a Selenocysteine Insertion Sequence (SECIS) Element
That Differs from Mammalian SECIS Elements but Directs Selenocysteine
Incorporation*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C until further use.
H3), substituting the TRR SECIS element for that of rat D1
(4). Sequences were confirmed by automated sequencing.
-mercaptoethanol, 50% glycerol, 0.5 mg/ml bromphenol
blue, pH 8.3) and heated for 5 min at 100 °C. Samples were subjected to SDS-PAGE analysis on 10% polyacrylamide gels (acrylamide:bis, 37.5:1), followed by electrotransfer to Immobilon (Millipore) in 20%
methanol, 25 mM Tris-HCl, pH 8.3, 192 mM
glycine. Membranes were blocked with 5% (w/v) nonfat milk in TBS-Tween
(20 mM Tris-HCl, pH 7.6, 140 mM NaCl, 0.1%
Tween 20), incubated with antibody 2098 (generous gift of John
Gasdaska), at 1:200 dilution in 1.25% (w/v) nonfat milk in TBS-Tween,
followed by incubation with peroxidase-conjugated secondary antibody
(NEN Life Science Products). Reaction products were visualized by
enhanced chemiluminescence (Amersham Pharmacia Biotech) and exposure to
X-Omat film (Eastman Kodak Co.). After extensive washing of the
membrane and decay of the chemiluminescent signal, the membrane was
subjected to autoradiography for 7 days.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
75Se labeling of worms and
bacteria. C. elegans were fed 75Se-labeled
bacteria as food source, homogenized, and subjected to SDS-PAGE
analysis, followed by autoradiography. Note that the upper two bands in
the 80-95 kDa range seen in C. elegans are also present in
the E. coli lane and are thus most likely of bacterial
origin. The major band not found in E. coli migrates with a
molecular mass of ~58 kDa.

View larger version (110K):
[in a new window]
Fig. 2.
Alignment of the C. elegans
thioredoxin reductase, human thioredoxin reductase, and C. elegans glutathione reductase protein sequences. The
alignment shows the conserved region around the selenocysteine and the
N-terminal extension. The peptide sequence to which the human TRR
antiserum was raised is marked by a line. Note the high
homology in this region between the C. elegans and human TRR
sequences.

View larger version (26K):
[in a new window]
Fig. 3.
Identification of the 58-kDa protein as a
human thioredoxin reductase homologue by Western analysis. Western
analysis of 75Se-labeled C. elegans homogenates
with an antibody against human TRR. Following Western analysis the
membrane was washed extensively with phosphate-buffered saline, dried,
and autoradiographed. The major band in the 75Se labeling
lane and the middle band in the hTRR antibody lane (arrow)
are superimposable, indicating that they likely originate from the same
protein. The bacterial selenoproteins are barely detectable in this
experiment, presumably due to exhaustion of the food source.

View larger version (12K):
[in a new window]
Fig. 4.
Predicted structure of the C. elegans thioredoxin reductase SECIS element.
Watson-Crick base pairing is indicated by lines and
non-Watson Crick base pairing by ovals. Nucleotides
conserved in other eukaryotic SECIS elements are shown in
bold. Note that the SECIS element starts with a GUGA
sequence instead of the AUGA consensus sequence. The G to A mutation
introduced in construct CB151 that disrupts the GA quartet is indicated
by the arrow.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
Note Added in Proof
![]()
FOOTNOTES
To whom correspondence and reprint requests should be addressed:
Thyroid Division, Dept. of Medicine, Brigham and Women's Hospital,
Harvard Medical School, Boston, MA 02115. Tel.: 617-525-5153; Fax:
617-731-4718; E-mail: berry@rascal.med.harvard.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Low, S. C.,
and Berry, M. J.
(1996)
Trends Biochem. Sci.
21,
203-208[CrossRef][Medline]
[Order article via Infotrieve]
2.
Berry, M. J.,
Banu, L.,
Harney, J. W.,
and Larsen, P. R.
(1993)
EMBO J.
12,
3315-3322[Medline]
[Order article via Infotrieve]
3.
Martin, G. W., III,
Harney, J. W.,
and Berry, M. J.
(1998)
RNA (N. Y.)
4,
65-73[Abstract]
4.
Martin, G. W., III,
Harney, J. W.,
and Berry, M. J.
(1996)
RNA (N. Y.)
2,
171-182[Abstract]
5.
Bosl, M. R.,
Takaku, K.,
Oshima, M.,
Nishimura, S.,
and Taketo, M. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5531-5534 6.
Ho, Y. S.,
Magnenat, J. L.,
Bronson, R. T.,
Cao, J.,
Gargano, M.,
Sugawara, M.,
and Funk, C. D.
(1997)
J. Biol. Chem.
272,
16644-16651 7.
Matsui, M.,
Oshima, M.,
Oshima, H.,
Takaku, K.,
Maruyama, T.,
Yodoi, J.,
and Taketo, M. M.
(1996)
Dev. Biol.
178,
179-185[CrossRef][Medline]
[Order article via Infotrieve]
8.
Gasdaska, P. Y.,
Gasdaska, J. R.,
Cochran, S.,
and Powis, G.
(1995)
FEBS Lett.
373,
5-9[CrossRef][Medline]
[Order article via Infotrieve]
9.
Gladyshev, V. N.,
Jeang, K. T.,
and Stadtman, T. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6146-6151 10.
Gasdaska, P. Y.,
Berggren, M. M.,
Berry, M. J.,
and Powis, G.
(1999)
FEBS Lett.
442,
105-111[CrossRef][Medline]
[Order article via Infotrieve]
11.
Lee, S. R.,
Kim, J. R.,
Kwon, K. S.,
Yoon, H. W.,
Levine, R. L.,
Ginsburg, A.,
and Rhee, S. G.
(1999)
J. Biol. Chem.
274,
4722-4734 12.
Miranda-Vizuete, A.,
Damdimopoulos, A. E.,
Pedrajas, J. R.,
Gustafsson, J. A.,
and Spyrou, G.
(1999)
Eur. J. Biochem.
261,
405-412[Medline]
[Order article via Infotrieve]
13.
Gromer, S.,
Wissing, J.,
Behne, D.,
Ashman, K.,
Schirmer, R. H.,
Flohe, L.,
and Becker, K.
(1998)
Biochem. J.
332,
591-592
14.
Nordberg, J.,
Zhong, L.,
Holmgren, A.,
and Arner, E. S.
(1998)
J. Biol. Chem.
273,
10835-10842 15.
Lee, B. J.,
Rajagopalan, M.,
Kim, Y. S.,
You, K. H.,
Jacobson, K. B.,
and Hatfield, D.
(1990)
Mol. Cell. Biol.
10,
1940-1949 16.
Mandel, S. J.,
Berry, M. J.,
Kieffer, J. D.,
Harney, J. W.,
Warne, R. L.,
and Larsen, P. R.
(1992)
J. Clin. Endocrinol. Metab.
75,
1133-1139[Abstract]
17.
Buettner, C.,
Harney, J. W.,
and Larsen, P. R.
(1998)
J. Biol. Chem.
273,
33374-33378 18.
Berry, M. J.,
Maia, A. L.,
Kieffer, J. D.,
Harney, J. W.,
and Larsen, P. R.
(1992)
Endocrinology
131,
1848-1852[Abstract]
19.
Heider, J.,
Baron, C.,
and Bock, A.
(1992)
EMBO J.
11,
3759-3766[Medline]
[Order article via Infotrieve]
20.
Gladyshev, V. N.,
Jeang, K. T.,
Wootton, J. C.,
and Hatfield, D. L.
(1998)
J. Biol. Chem.
273,
8910-8915 21.
Berry, M. J.,
Kieffer, J. D.,
Harney, J. W.,
and Larsen, P. R.
(1991)
J. Biol. Chem.
266,
14155-14158 22.
Walczak, R.,
Carbon, P.,
and Krol, A.
(1998)
RNA (N. Y.)
4,
74-84[Abstract]
23.
Hatfield, D. L.,
Gladyshev, V. N.,
Park, J.,
Park, S. I.,
Chittum, H. S.,
Baek, H. J.,
Carlson, B. A.,
Yang, E. S.,
Moustafa, M. E.,
and Lee, B. J.
(1999)
Compr. Nat. Prod. Chem.
4,
353-380
24.
Tripp, C.,
Frank, R. S.,
Selkirk, M. E.,
Tang, L.,
Grieve, M. M.,
Frank, G. R.,
and Grieve, R. B.
(1998)
Exp. Parasitol.
88,
43-50[CrossRef][Medline]
[Order article via Infotrieve]
25.
Gladyshev, V. N.,
Krause, M.,
Xu, X. M.,
Korotkov, K. V.,
Kryukov, G. V.,
Sun, Q. A.,
Lee, B. J.,
Wootton, J. C.,
and Hatfield, D. L.
(1999)
Biochem. Biophys. Res. Commun.
259,
244-249[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Jee, L. Vanoaica, J. Lee, B. J. Park, and J. Ahnn Thioredoxin is related to life span regulation and oxidative stress response in Caenorhabditis elegans Genes Cells, December 1, 2005; 10(12): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Taskov, C. Chapple, G. V. Kryukov, S. Castellano, A. V. Lobanov, K. V. Korotkov, R. Guigo, and V. N. Gladyshev Nematode selenoproteome: the use of the selenocysteine insertion system to decode one codon in an animal genome? Nucleic Acids Res., April 20, 2005; 33(7): 2227 - 2238. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Krnajski, T.-W. Gilberger, R. D. Walter, A. F. Cowman, and S. Muller Thioredoxin Reductase Is Essential for the Survival of Plasmodium falciparum Erythrocytic Stages J. Biol. Chem., July 12, 2002; 277(29): 25970 - 25975. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Korotkov, S. V. Novoselov, D. L. Hatfield, and V. N. Gladyshev Mammalian Selenoprotein in Which Selenocysteine (Sec) Incorporation Is Supported by a New Form of Sec Insertion Sequence Element Mol. Cell. Biol., March 1, 2002; 22(5): 1402 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fagegaltier, A. Lescure, R. Walczak, P. Carbon, and A. Krol Structural analysis of new local features in SECIS RNA hairpins Nucleic Acids Res., July 15, 2000; 28(14): 2679 - 2689. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. Kryukov, V. M. Kryukov, and V. N. Gladyshev New Mammalian Selenocysteine-containing Proteins Identified with an Algorithm That Searches for Selenocysteine Insertion Sequence Elements J. Biol. Chem., November 26, 1999; 274(48): 33888 - 33897. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Krnajski, T.-W. Gilberger, R. D. Walter, and S. Muller Intersubunit Interactions in Plasmodium falciparum Thioredoxin Reductase J. Biol. Chem., December 22, 2000; 275(52): 40874 - 40878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Lee, S. Bar-Noy, J. Kwon, R. L. Levine, T. C. Stadtman, and S. G. Rhee Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity PNAS, March 14, 2000; 97(6): 2521 - 2526. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |